Suppr超能文献

中国天然产物的生物筛选与药物创新

Biological screening of natural products and drug innovation in China.

作者信息

Wang Ming-Wei, Hao Xiaojiang, Chen Kaixian

机构信息

The National Centre for Drug Screening, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, People's Republic of China.

出版信息

Philos Trans R Soc Lond B Biol Sci. 2007 Jun 29;362(1482):1093-105. doi: 10.1098/rstb.2007.2036.

Abstract

Natural products have been applied to human healthcare for thousands of years. Drug discovery in ancient times was largely by chance and based on clinical practices. As understanding of therapeutic benefits deepens and demands for natural products increase, previously serendipitous discoveries evolve into active searches for new medicines. Many drugs presently prescribed by physicians are either directly isolated from plants or are artificially modified versions of natural products. Scientists are looking for lead compounds with specific structures and pharmacological effects often from natural sources. Experiences and successes of Chinese scientists in this specialized area have resulted in a number of widely used drugs. The tremendous progress made in life sciences has not only revealed many pathological processes of diseases, but also led to the establishment of various molecular and cellular bioassays in conjunction with high-throughput technologies. This is advantageous and permits certain natural compounds that are difficult to isolate and purify, and compounds that are difficult to synthesize, to be assayed. The transition from traditional to empirical and to molecular screening will certainly increase the probability of discovering new leads and drug candidates from natural products.

摘要

天然产物应用于人类医疗保健已有数千年历史。古代的药物发现很大程度上是偶然的,且基于临床实践。随着对治疗益处的理解不断深入以及对天然产物的需求增加,以前偶然的发现逐渐演变为对新药的积极探索。目前医生开具的许多药物要么直接从植物中分离出来,要么是天然产物的人工改性版本。科学家们常常从天然来源寻找具有特定结构和药理作用的先导化合物。中国科学家在这一专业领域的经验和成功促成了许多广泛使用的药物。生命科学取得的巨大进展不仅揭示了许多疾病的病理过程,还导致了结合高通量技术建立各种分子和细胞生物测定法。这具有优势,使得某些难以分离和纯化的天然化合物以及难以合成的化合物能够得到测定。从传统筛选到经验性筛选再到分子筛选的转变肯定会增加从天然产物中发现新先导化合物和候选药物的可能性。

相似文献

1
Biological screening of natural products and drug innovation in China.中国天然产物的生物筛选与药物创新
Philos Trans R Soc Lond B Biol Sci. 2007 Jun 29;362(1482):1093-105. doi: 10.1098/rstb.2007.2036.
3
The strategies and techniques of drug discovery from natural products.天然产物药物发现的策略与技术。
Pharmacol Ther. 2020 Dec;216:107686. doi: 10.1016/j.pharmthera.2020.107686. Epub 2020 Sep 19.
5
Natural products as leads to anticancer drugs.作为抗癌药物先导物的天然产物。
Clin Transl Oncol. 2007 Dec;9(12):767-76. doi: 10.1007/s12094-007-0138-9.
9
Traditional Chinese medicine--sea urchin.传统中药——海胆。
Mini Rev Med Chem. 2014;14(6):537-42. doi: 10.2174/1389557514666140529224147.
10
High-throughput screening for bioactive components from traditional Chinese medicine.中药生物活性成分的高通量筛选
Comb Chem High Throughput Screen. 2010 Dec;13(10):837-48. doi: 10.2174/138620710793360257.

引用本文的文献

10
YaTCM: Yet another Traditional Chinese Medicine Database for Drug Discovery.YaTCM:另一个用于药物发现的中医数据库。
Comput Struct Biotechnol J. 2018 Nov 23;16:600-610. doi: 10.1016/j.csbj.2018.11.002. eCollection 2018.

本文引用的文献

2
Multicomponent therapeutics for networked systems.用于网络系统的多组分疗法。
Nat Rev Drug Discov. 2005 Jan;4(1):71-8. doi: 10.1038/nrd1609.
4
Effects of artemisinin-tagged holotransferrin on cancer cells.青蒿素标记的全转铁蛋白对癌细胞的影响。
Life Sci. 2005 Jan 28;76(11):1267-79. doi: 10.1016/j.lfs.2004.08.020. Epub 2004 Nov 23.
10
Identification of phase I and phase II metabolites of Guanfu base A hydrochloride in human urine.
Eur J Drug Metab Pharmacokinet. 2003 Oct-Dec;28(4):265-72. doi: 10.1007/BF03220178.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验